Literature DB >> 32743391

Renal primitive neuroectodermal tumor with elevated plasma adrenocorticotropic hormone levels: A case report.

Nobuaki Shimizu1, Masaru Hasumi1, Tatsuya Hamano1,2, Misa Iijima3, Takako Yoshioka4, Yuto Yamazaki5, Hironobu Sasano5.   

Abstract

INTRODUCTION: Primitive neuroectodermal tumors are small round-cell tumors - Ewing sarcoma family, frequently occurring in the extremities, but rarely in the kidney. CASE
PRESENTATION: A 58-year-old woman presented with whole-body edema and weakness of lower limb muscles. Computed tomography revealed a left renal tumor, and the plasma adrenocorticotropic hormone level was elevated. The tumor was surgically removed without complications, her plasma adrenocorticotropic hormone reverted to normal levels, and symptoms disappeared after surgery. Histopathological examination revealed a primitive neuroectodermal tumor arising in her kidney. The patient was alive without metastasis 3 years after the surgery.
CONCLUSION: We report the first case of renal primitive neuroectodermal tumor accompanying elevated plasma adrenocorticotropic hormone levels which are thought to be produced and secreted in an ectopic fashion.
© 2019 The Authors. IJU Case Reports published by John Wiley & Sons Australia, Ltd on behalf of the Japanese Urological Association.

Entities:  

Keywords:  ACTH; Ewing sarcoma; PNET; kidney

Year:  2019        PMID: 32743391      PMCID: PMC7292057          DOI: 10.1002/iju5.12057

Source DB:  PubMed          Journal:  IJU Case Rep        ISSN: 2577-171X


adrenocorticotropic hormone cluster of differentiation cytokeratin Ewing sarcoma family of tumors Ewing's sarcoma Ewing sarcoma breakpoint region 1 fluorescence in situ hybridization Friend leukemia integration 1 lactate dehydrogenase magnetic resonance imaging neurokinin 2 Nk2 Homeobox 2 primitive neuroectodermal tumor reverse transcription polymerase chain reaction Renal PNET is rare. We report the first case of renal PNET accompanying with elevated plasma ACTH, thought to be produced and secreted in an ectopic fashion.

Introduction

PNETs are solid tumors histologically consisting of premature small round cells with frequent rosette‐like formation. Morphological differential diagnosis of small round‐cell tumors is well‐known in surgical pathology, but genetic and immunohistochemical analysis contributes to greater accuracy.1, 2 PNET is a member of the ESFT and shares a common chromosomal translocation with EWS.2, 3 Renal primary PNETs are rare but the number of reported cases has increased since the mid‐1990s, possibly due to use of immunohistochemistry in differential diagnosis. More than 100 cases of renal primary PNETs have been reported in the English literature.4 However, adult PNET with high ACTH has not been reported. Therefore, we report a case of renal primary PNET associated with increased plasma ACTH levels.

Case presentation

A 58‐year‐old woman presented with 1 month of whole‐body edema, moon‐like facies, and weakness of lower limb muscles. She had elevated LDH, hypokalemia and hypochloremia. Serum ACTH and cortisol were markedly elevated (Table 1).
Table 1

Pre‐ and postoperative laboratory findings

Pre‐operativePost‐operativeNormal range (unit)
Body weight (kg)6459
LDH652188119–229 (U/L)
Potassium1.64.83.5–5.0 (mmol/L)
Chloride9211098–108 (mmol/L)
ACTH384.932.87.2–63.3 (pg/mL)
Cortisol44.314.44.5–21.2 (μg/dL)
Adrenaline0.020.03<0.17 (ng/mL)
Noradrenaline0.470.550.15–0.57 (ng/mL)
Dopamine<0.01<0.02< 0.03 (ng/mL)
Pre‐ and postoperative laboratory findings Multiparametric MRI demonstrated soft tissue shadows protruding from the renal pelvis to the dorsal cortex and further backwards, with surrounding hematoma (Fig. 1a).
Figure 1

MRI showing PNET protruding from the renal pelvis to the dorsal cortex with hematoma (a). Enhanced computed tomography with contrast medium showing the large hypovascular tumor and normal adrenal glands (arrow) (b). The tumor was associated with hemorrhage and necrosis (c). Brain MRI showed the hypophysis was normal in size (arrow) (d).

MRI showing PNET protruding from the renal pelvis to the dorsal cortex with hematoma (a). Enhanced computed tomography with contrast medium showing the large hypovascular tumor and normal adrenal glands (arrow) (b). The tumor was associated with hemorrhage and necrosis (c). Brain MRI showed the hypophysis was normal in size (arrow) (d). In enhanced computed tomography, it was hypovascular tumor and both adrenal glands were normal size (Fig. 1b). If ACTH stimulation continued for long time, the adrenal gland might have showed hypertrophy. But it took only 1 month from the onset of syndrome to diagnosis. Although we could not confirm the brain before surgery, no tumor was observed in the pituitary gland in brain MRI on day 5 after surgery (Fig. 1d). A left renal tumor with hematoma was clinically diagnosed and radical left nephrectomy was performed. Macroscopically, intratumoral hemorrhage and necrosis were observed, protruding from the renal pelvis to outside of the kidney, measuring 7 cm in greatest diameter (Fig. 1c). Histopathology of the resected tumor revealed diffuse proliferation of small cells with a high nuclear‐cytoplasmic ratio in most of the tissue specimens. Nuclear mitoses were scattered, and rosette formation was detected (Fig. 2a).
Figure 2

Diffusely proliferated small tumor cells forming rosettes (arrow) on H&E (a). Immunostaining for CD99 (b) and NKX2.2 (c). A split signal was observed via FISH using an EWSR1 dual color break apart probe. In normal cells, the red and green signals are very close or appear yellow (yellow arrowhead). In gene‐translocated cells, two signals are split (green and red arrows) (d).

Diffusely proliferated small tumor cells forming rosettes (arrow) on H&E (a). Immunostaining for CD99 (b) and NKX2.2 (c). A split signal was observed via FISH using an EWSR1 dual color break apart probe. In normal cells, the red and green signals are very close or appear yellow (yellow arrowhead). In gene‐translocated cells, two signals are split (green and red arrows) (d). Immunohistology revealed that the tumor cells were diffusely positive for CD99 (Fig. 2b). FISH analysis of translocations related to the EWSR1 gene revealed a split signal, suggesting a translocation associated with EWSR1 (Fig. 2d). Based on these findings, the tumor was diagnosed as PNET. The edema improved and body weight decreased by 4.7 kg after surgery. The white blood cell count and serum levels of LDH, potassium, and chloride were also normalized, as were both ACTH and cortisol following surgery. The patient was alive without recurrence 3 years after surgery, and ACTH and cortisol levels were also within normal range at the time of last evaluation.

Discussion

We reported a case of renal PNET with elevated plasma ACTH levels. PNET is generally postulated to originate from neural crest, embryonic, or mesenchymal stem cells, but exact origins remain unknown.2, 5 PNET commonly develops in the limbs or soft tissues of young adults,3 but rarely in kidneys. The first case of renal PNET was reported by Seemayer et al. in 1975.6 Hamidi et al. reported most of the patients are observed in a range of 10–39 years of age, most common symptoms are abdominal pain (68–85%), 3‐ and 5‐year overall survival rates in patients with renal PNET were 42–60%.7 Ellinger et al. showed the PNET on urogenital organs may show good prognosis if it is not palpable and is a localized disease.8 Because our case fulfilled these conditions, the patient was able to survive for more than 3 years. Histologically, PNET is composed of premature small round cells that are sometimes arranged to form rosettes. Intratumoral hemorrhage and necrosis are often detected and histopathological features of PNET can vary greatly, resembling clear cell sarcoma or malignant peripheral nerve sheath tumor.3, 9 Therefore, histological differential diagnosis can include blastemal dominant Wilms tumor, metastatic neuroblastoma, rhabdomyosarcoma, lymphoma, synovial sarcoma, and other rare malignancies. In addition, these small round‐cell tumors are often undifferentiated, which can make histopathological differential diagnosis more difficult. Therefore, both immunohistochemistry and molecular studies are needed for accurate diagnosis.1 PNET is positive for CD99 and FLI‐1, but Wilms tumor, neuroblastoma, rhabdomyosarcoma, and synovial sarcoma may also be positive for these markers.9 Therefore, extensive immunohistological analysis is generally required for definitive diagnosis, as in this case (Table 2).
Table 2

Results of immunohistochemical staining

AntibodyTargetResult
CD45pan LeukocyteNegative
CD3pan T cellNegative
CD20pan B cellNegative
CD10B‐cell ABL2Negative
CK AE1/3Multi‐cytokeratinNegative
CK7Epithelial tumorNegative
CK20Epithelial tumorNegative
Chromogranin ANeuroendocrine tumorNegative
SynaptophysinNeuroendocrine tumorPositive
S100Nervous systemPartly positive
CD56NK/neuroendocrine tumorPartly positive
CD57NK/neuroectodermPartly positive
CD117Stem cellNegative
CD34Stem cell, vascular endothelialNegative
CD99MIC2Positive
DesminMuscleNegative
HHF35Muscler actinNegative
Wilms tumor 1Wilms tumor, renal cancerNegative
HMB45MelanomaNegative
FLI‐1EWSPartly positive
NKX2.2EWSPositive
ACTHACTHNegative
Results of immunohistochemical staining The NKX2.2 antibody has recently been reported as a useful diagnostic marker of ESFT. NKX2.2 is a member of the nuclear transcription factor NK2 family and the EWS/FLI‐1 fusion protein produced via translocation is considered to act on nuclear NKX2.2, thereby contributing to tumorigenesis and metastasis.9 In the present case, the tumor cells were immunohistochemically positive for NKX2.2 in the nuclei, consistent with the diagnosis of PNET (Fig. 2c). Genetic testing can be very useful in the definitive diagnosis of PNET. As PNET shares a common chromosomal translocation at (11; 22) (q 24; q 12) with EWS, it is now regarded as a member of the ESFT.5 Molecular‐level analysis via RT‐PCR is highly specific but requires frozen tissue specimens because fusion transcripts are not always detectable in 10% formalin‐fixed and paraffin‐embedded tissue. Therefore, RT‐PCR cannot be performed in the great majority of cases because the diagnosis was made in 10% formalin fixed and paraffin embedded tissue specimens. Therefore, FISH using formalin‐fixed specimens has been extensively applied to detect EWS gene rearrangements.10 In the present case, EWS translocation was also detected via FISH. ACTH and cortisol levels were elevated. When the plasma level of cortisol increased, normally ACTH level would be reduced by negative feedback. But in this case, both plasma levels were elevated. Moreover there was no tumor in hypophysis. Therefore we highly suspected that ACTH have been autonomously produced. A dexamethasone suppression test should have been performed to identify the cause of elevated ACTH, but surgery was prioritized. After the tumor was removed, both hormone levels markedly decreased, suggesting that ACTH was ectopically produced in this resected tumor. However, the tumor was immunohistochemically negative for ACTH. We therefore speculated that ACTH levels in this large tumor might have been below the detection limit of the antibody used in immunohistochemistry; however, such a large tumor may be able to produce sufficient ACTH to raise the level in plasma. In another way of thinking, if the ACTH producing cells was present in a very limited part of the tumor, it may be difficult to find. Anyway further investigation is required for clarification. To the best of our knowledge, ESFT with elevated ACTH levels has been reported in two children with EWS.11 Including our patient, these three cases suggest that some ESFTs may be associated with ACTH production. EWS/FLI‐1 fusion protein may be involved, as a reported transcriptional modulator for oncogenic transformation.12 In summary, we report the first case of renal PNET with elevated ACTH and cortisol levels. However, the relationship between ESFT and ACTH production remains unknown. Further research is needed to clarify the pathogenesis of PNET and ACTH‐producing tumors.

Conflict of interest

The authors declare no conflict of interest.
  11 in total

1.  Peripheral neuroectodermal tumors.

Authors:  T A Seemayer; W L Thelmo; R P Bolande; F W Wiglesworth
Journal:  Perspect Pediatr Pathol       Date:  1975

2.  A large and metastatic primitive neuroectodermal tumor of the kidney.

Authors:  Nurullah Hamidi; Barış Esen; Hale Kıvrak; Ayşe Sertçelik; Ömer Gülpınar
Journal:  Turk J Urol       Date:  2014-07-18

3.  A practical approach to the clinical diagnosis of Ewing's sarcoma/primitive neuroectodermal tumour and other small round cell tumours sharing EWS rearrangement using new fluorescence in situ hybridisation probes for EWSR1 on formalin fixed, paraffin wax embedded tissue.

Authors:  U Yamaguchi; T Hasegawa; Y Morimoto; U Tateishi; M Endo; F Nakatani; A Kawai; H Chuman; Y Beppu; M Endo; H Kurotaki; K Furuta
Journal:  J Clin Pathol       Date:  2005-10       Impact factor: 3.411

4.  NKX2.2 is a useful immunohistochemical marker for Ewing sarcoma.

Authors:  Akihiko Yoshida; Shigeki Sekine; Koji Tsuta; Masashi Fukayama; Koh Furuta; Hitoshi Tsuda
Journal:  Am J Surg Pathol       Date:  2012-07       Impact factor: 6.394

5.  Clinical and pathological features of primary neuroectodermal tumor/Ewing sarcoma of the kidney.

Authors:  Emanuela Risi; Roberto Iacovelli; Amelia Altavilla; Daniele Alesini; Antonella Palazzo; Claudia Mosillo; Patrizia Trenta; Enrico Cortesi
Journal:  Urology       Date:  2013-06-22       Impact factor: 2.649

6.  Ectopic ACTH syndrome in children and adolescents.

Authors:  Julie More; Jacques Young; Yves Reznik; Gérald Raverot; Françoise Borson-Chazot; Vincent Rohmer; Eric Baudin; Régis Coutant; Antoine Tabarin
Journal:  J Clin Endocrinol Metab       Date:  2011-02-23       Impact factor: 5.958

Review 7.  Primitive neuroectodermal tumor: rare, highly aggressive differential diagnosis in urologic malignancies.

Authors:  Jörg Ellinger; Patrick J Bastian; Stefan Hauser; Katharina Biermann; Stefan C Müller
Journal:  Urology       Date:  2006-08       Impact factor: 2.649

Review 8.  Primitive neuroectodermal tumor and Ewing's sarcoma.

Authors:  L P Dehner
Journal:  Am J Surg Pathol       Date:  1993-01       Impact factor: 6.394

Review 9.  Undifferentiated tumor: true identity by immunohistochemistry.

Authors:  Armita Bahrami; Luan D Truong; Jae Y Ro
Journal:  Arch Pathol Lab Med       Date:  2008-03       Impact factor: 5.534

10.  Mechanism and relevance of EWS/FLI-mediated transcriptional repression in Ewing sarcoma.

Authors:  S Sankar; R Bell; B Stephens; R Zhuo; S Sharma; D J Bearss; S L Lessnick
Journal:  Oncogene       Date:  2012-11-26       Impact factor: 9.867

View more
  1 in total

1.  A rare case report of renal ewing sarcoma/primitive neuroectodermal tumor with ACTH production.

Authors:  Weipu Mao; Jiajia Xu; Haowen Lu; Yali Wang; Lihua Zhang; Ming Chen
Journal:  BMC Urol       Date:  2022-07-11       Impact factor: 2.090

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.